Skip to main content
. 2022 May 28;14(11):2677. doi: 10.3390/cancers14112677

Table 2.

Advantages and disadvantages of nanosystems used for RNA delivery.

Nanosystems Advantages Disadvantages References
Lipid-based nanosystems Liposomes
  • -

    high biodegradability

  • -

    cationic systems present high compaction efficiency

  • -

    cost-effectiveness

  • -

    off-target effects

  • -

    cytotoxicity of cationic systems

[43]
SLN
  • -

    easy large-scale production

  • -

    higher loading capacity than liposomes

  • -

    high cargo bioavailability

  • -

    controlled cargo release

  • -

    high toxicity when derived from cationic lipids

  • -

    crystallization upon long-term storage

  • -

    stability issues

[43,65,66]
Exosomes
  • -

    low immunogenicity

  • -

    high biocompatibility

  • -

    high protection of nucleic acids

  • -

    cell targeting capacity

  • -

    heterogeneity of natural matrix

  • -

    limited large-scale production

  • -

    limited transfection efficiency

[72]
Polymeric systems
  • -

    ease of synthesis and surface modification

  • -

    versatility of structural conformations

  • -

    biodegradability (in some cases through derivatization)

  • -

    non-degradable polymers tend to accumulate in tissues inducing cytotoxicity

  • -

    in vivo metabolism and elimination routes still unknown

[134]
Inorganic nanoparticles Metallic (Au, iron)
  • -

    variability in size, structure and geometry

  • -

    ease of functionalization

  • -

    limited information concerning biocompatibility and cytotoxicity

[113,135,136]
Carbon nanotubes
  • -

    possibilities of surface modification

  • -

    low cytotoxicity and good biocompatibility of modified systems

  • -

    high loading capacity

  • -

    limited in vivo studies developed

[115,116]
Silica
  • -

    large surface area and thus an enhanced loading capacity

  • -

    low toxicity

  • -

    not able to induce endosomal escape (must be chemically modified)

  • -

    limited information about biocompatibility and biodistribution available

[124,125]